Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alexander Kurtenbach"'
Autor:
Henrik Daub, Josef Wissing, György Kéri, Matt Cotten, Bert Klebl, Stefan Müller, Martina Weber, Alexander Kurtenbach, Stephanie Blencke, Klaus Godl, Zoltán Greff, Dirk Brehmer
Supplementary Methods and Figure from Cellular Targets of Gefitinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61c7a36d033024c906dd8d464db7ab66
https://doi.org/10.1158/0008-5472.22361673.v1
https://doi.org/10.1158/0008-5472.22361673.v1
Autor:
Henrik Daub, Josef Wissing, György Kéri, Matt Cotten, Bert Klebl, Stefan Müller, Martina Weber, Alexander Kurtenbach, Stephanie Blencke, Klaus Godl, Zoltán Greff, Dirk Brehmer
Supplementary Table 2 from Cellular Targets of Gefitinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fef01c4943db660c7fa2c6553b62f51
https://doi.org/10.1158/0008-5472.22333051.v1
https://doi.org/10.1158/0008-5472.22333051.v1
Autor:
Henrik Daub, Josef Wissing, György Kéri, Matt Cotten, Bert Klebl, Stefan Müller, Martina Weber, Alexander Kurtenbach, Stephanie Blencke, Klaus Godl, Zoltán Greff, Dirk Brehmer
Supplementary Table 1 from Cellular Targets of Gefitinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3881c8958e642fecbb5e0f473b8a051c
https://doi.org/10.1158/0008-5472.22361670
https://doi.org/10.1158/0008-5472.22361670
Autor:
Henrik Daub, Josef Wissing, György Kéri, Matt Cotten, Bert Klebl, Stefan Müller, Martina Weber, Alexander Kurtenbach, Stephanie Blencke, Klaus Godl, Zoltán Greff, Dirk Brehmer
Targeted inhibition of protein kinases with small molecule drugs has evolved into a viable approach for anticancer therapy. However, the true selectivity of these therapeutic agents has remained unclear. Here, we used a proteomic method to profile th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46df888bca05c3069e009f3f92364397
https://doi.org/10.1158/0008-5472.c.6493059.v1
https://doi.org/10.1158/0008-5472.c.6493059.v1
Publikováno v:
Antiviral Chemistry and Chemotherapy. 16:69-90
The development of novel antiviral drugs against hepatitis C is a challenging and competitive area of research. Progress of this research has been hampered due to the quasispecies nature of the hepatitis C virus, the absence of cellular infection mod
Autor:
Henrik Daub, Josef Wissing, Alexander Kurtenbach, Axel Ullrich, Stephanie Blencke, Peter Habenberger, Matthew Cotten, Julia Dennenmoser
Publikováno v:
Journal of Virology. 76:8124-8137
Phosphorylation of hepatitis B virus (HBV) core protein has recently been shown to be a prerequisite for pregenomic RNA encapsidation into viral capsids, but the host cell kinases mediating this essential step of the HBV replication cycle have not be
Autor:
Sabine Obert, Matthew Cotten, Dennis Strand, Alexander Kurtenbach, Henrik Daub, Ralf Bartenschlager, Monika Morbitzer, Thomas Herget, Josef Wissing, Nicole Krieger, Birgit Zech, Kostas Salassidis, Stephanie Blencke
Publikováno v:
The Journal of general virology. 84(Pt 3)
The hepatitis C virus (HCV) NS5A protein is highly phosphorylated by cellular protein kinases. To study how NS5A might be integrated in cellular kinase signalling, we isolated phosphoproteins from HuH-7 hepatoma cells that specifically interacted wit